Simplex Trading, LLC Akebia Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.32 - $0.67 $27,836 - $58,282	-86,989 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$0.72 - $2.93 $23,006 - $93,625	31,954 Added 58.06%	86,989 $62,000
Q4 2021 Feb 23, 2022	BUY	$2.26 - $3.34 $124,379 - $183,816	55,035 New	55,035 $124,000
Q2 2021 Aug 12, 2021	SELL	$2.83 - $4.2 $136,173 - $202,095	-48,118 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$2.92 - $5.06 $153,895 - $266,682	-52,704 Reduced 52.27%	48,118 $162,000
Q4 2020 Feb 02, 2021	BUY	$2.22 - $3.78 $7,488 - $12,749	3,373 Added 3.46%	100,822 $282,000
Q3 2020 Oct 14, 2020	BUY	$2.39 - $13.08 $126,194 - $690,637	52,801 Added 118.26%	97,449 $244,000
Q2 2020 Jul 13, 2020	SELL	$6.67 - $13.58 $479,826 - $976,918	-71,938 Reduced 61.7%	44,648 $606,000
Q1 2020 Apr 29, 2020	SELL	$4.1 - $10.24 $33,185 - $82,882	-8,094 Reduced 6.49%	116,586 $883,000
Q4 2019 Feb 05, 2020	BUY	$3.16 - $6.73 $337,137 - $718,016	106,689 Added 593.01%	124,680 $787,000
Q3 2019 Oct 15, 2019	SELL	$3.55 - $5.4 $113,088 - $172,022	-31,856 Reduced 63.91%	17,991 $70,000
Q2 2019 Jul 26, 2019	BUY	$4.1 - $8.05 $54,763 - $107,523	13,357 Added 36.6%	49,847 $241,000
Q1 2019 Apr 18, 2019	BUY	$5.41 - $8.73 $197,410 - $318,557	36,490 New	36,490 $0
Q4 2018 Jan 16, 2019	SELL	$5.39 - $9.15 $182,521 - $309,846	-33,863 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$7.44 - $10.65 $109,033 - $156,075	-14,655 Reduced 30.21%	33,863 $299,000
Q2 2018 Jul 30, 2018	BUY	$9.15 - $11.34 $427,698 - $530,065	46,743 Added 2633.41%	48,518 $484,000
Q1 2018 Apr 26, 2018	SELL	$9.53 - $15.68 $3,297 - $5,425	-346 Reduced 16.31%	1,775 $16,000
Q4 2017 Jan 10, 2018	SELL	$14.24 - $19.59 $4,556 - $6,268	-320 Reduced 13.11%	2,121 $31,000
Q3 2017 Oct 25, 2017	BUY	$13.06 - $19.67 $31,879 - $48,014	2,441	2,441 $48,000

Others Institutions Holding AKBA

# of Institutions

120

Shares Held

54.8M

Call Options Held

291K

Put Options Held

179K

Black Rock Inc. New York, NY

11.6M
Shares

$20.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$17.7 Million
0.0% of portfolio
Satter Management Co., L.P.

5.75M
Shares

$10.1 Million
13.23% of portfolio
Geode Capital Management, LLC Boston, MA

4.75M
Shares

$8.37 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.72M
Shares

$6.54 Million
0.01% of portfolio

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $324M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account